Plan-level and provider-level variation in systemic therapy receipt among Medicare Advantage beneficiaries with advanced cancer.
79 Background: Prompt initiation of systemic therapy is a critical determinant of survival in advanced cancer. Medicare Advantage (MA) plans commonly employ prior authorization, which may affect timely systemic therapy initiation. Moreover, healthcare providers may differ in their capacity to navigate these req...